These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15639795)

  • 1. Surface plasmon resonance for the analysis of beta-amyloid interactions and fibril formation in Alzheimer's disease research.
    Aguilar MI; Small DH
    Neurotox Res; 2005; 7(1-2):17-27. PubMed ID: 15639795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
    Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between Alzheimer's Abeta1-42 peptide and DNA detected by surface plasmon resonance.
    Barrantes A; Rejas MT; Benítez MJ; Jiménez JS
    J Alzheimers Dis; 2007 Dec; 12(4):345-55. PubMed ID: 18198421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the interactions of copper and zinc ions with β-amyloid peptides by a surface plasmon resonance biosensor.
    Yao F; Zhang R; Tian H; Li X
    Int J Mol Sci; 2012; 13(9):11832-11843. PubMed ID: 23109885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
    de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
    Kang MK; Lee J; Nguyen AH; Sim SJ
    Biosens Bioelectron; 2015 Oct; 72():197-204. PubMed ID: 25982728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface plasmon resonance imaging of amyloid-β aggregation kinetics in the presence of epigallocatechin gallate and metals.
    Cheng XR; Hau BY; Veloso AJ; Martic S; Kraatz HB; Kerman K
    Anal Chem; 2013 Feb; 85(4):2049-55. PubMed ID: 23276205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies.
    Ramakrishnan M; Kandimalla KK; Wengenack TM; Howell KG; Poduslo JF
    Biochemistry; 2009 Nov; 48(43):10405-15. PubMed ID: 19775170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease.
    Ryan TM; Roberts BR; McColl G; Hare DJ; Doble PA; Li QX; Lind M; Roberts AM; Mertens HD; Kirby N; Pham CL; Hinds MG; Adlard PA; Barnham KJ; Curtain CC; Masters CL
    J Neurosci; 2015 Feb; 35(7):2871-84. PubMed ID: 25698727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginnalin A Inhibits Aggregation, Reverses Fibrillogenesis, and Alleviates Cytotoxicity of Amyloid β(1-42).
    Fan Q; Liu Y; Wang X; Zhang Z; Fu Y; Liu L; Wang P; Ma H; Ma H; Seeram NP; Zheng J; Zhou F
    ACS Chem Neurosci; 2020 Feb; 11(4):638-647. PubMed ID: 31967782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of resveratrol to monomer and fibril amyloid beta.
    Ge JF; Qiao JP; Qi CC; Wang CW; Zhou JN
    Neurochem Int; 2012 Dec; 61(7):1192-201. PubMed ID: 22981725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface plasmon resonance for the label-free detection of Alzheimer's β-amyloid peptide aggregation.
    Palladino P; Aura AM; Spoto G
    Anal Bioanal Chem; 2016 Jan; 408(3):849-54. PubMed ID: 26558762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
    Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.